Director, Search & Evaluation Early Ta Lead (Haem)

Csl

Maidenhead

Hybrid

GBP 180,000 - 240,000

Full time

11 days ago

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

CSL Behring is expanding its external innovation capability, seeking a Director of Search & Evaluation to shape the Haematology portfolio. The role leads strategic sourcing and evaluation of early assets from preclinical to Phase 1, developing partnering strategies and driving transactions in collaboration with Business Development.

Based in a hybrid model onsite at Maidenhead (UK) with other hub sites, you will lead the Therapeutic Area Leadership Team, build a robust external pipeline, and

Qualifications

  • Significant tenure in biopharma with significant experience in external innovation, search & evaluation, or business development.
  • Advanced degree required (PhD, MD, or equivalent).
  • Must have deep scientific expertise in Haematology.
  • Proven track record of leading due diligence and closing early-stage deals.
  • Strong network within biotech, academia, and pharma BD organizations.

Responsibilities

  • Lead strategic sourcing and evaluation of external innovation opportunities in Haematology.
  • Coordinate due diligence and deal negotiations for preclinical to Phase 1 assets.
  • Develop early partnering strategies and onboarding approaches for priority assets.
  • Drive cross-functional due diligence with scientific, regulatory, and commercial assessments.
  • Represent CSL externally at conferences and build biotech and academic partnerships.

Skills

External innovation
Search & Evaluation
Business development
Biopharma
Haematology

Education

Advanced degree (PhD/MD or equivalent)

Job description

CSL is expanding its external innovation capability, and we're looking for a Director of Search & Evaluation to help shape the future of our Haematology portfolio. We are seeking a Director of Search & Evaluation to lead strategic sourcing and evaluation of external innovation opportunities in the Haematology therapeutic area. Embedded within the Therapeutic Area Leadership Team (TALT), this position will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development. To be hybrid-based onsite (3 days a week) at one of our R&D hub sites: Zurich (CH), Maidenhead (UK), Waltham (US), King of Prussia (US). This position cannot be held remotely.

Main Responsibilities & Accountabilities
  • Serve as the senior Early S&E leader within the TALT, influencing therapeutic strategy and ensuring external innovation priorities are integrated into portfolio planning.
  • Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets, building a robust pipeline of opportunities aligned with TA strategy.
  • Co-lead internal meetings (with Late Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within Haematology. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations.
  • Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets.
  • Drive cross-functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments to inform governance decisions.
  • Transaction Execution: Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution.
  • Represent the TA externally, leading sourcing activities at specialized conferences and cultivating relationships with biotech, academia, and investment communities.
Qualifications & Experience Requirements
  • Significant tenure in biopharma with significant experience in external innovation, search & evaluation, or business development.
  • Advanced degree required (PhD, MD, or equivalent).
  • Must have deep scientific expertise in Haematology.
  • Proven track record of leading due diligence and closing early-stage deals.
  • Strong network within biotech, academia, and pharma BD organizations.
About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit [https://www.csl.com/](https://www.csl.com/) and CSL Plasma at [https://www.cslplasma.com/](https://www.cslplasma.com/). Our Benefits For more information on CSL benefits visit [How CSL Supports Your Well-being | CSL](https://www.csl.com/) You Belong at CSL At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging Equal Opportunity Employer CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Director, Haematology External Innovation (Early S&E)
Director, Haematology External Innovation (Early S&E)

Csl • Maidenhead

Hybrid
GBP 180,000 - 240,000
Associate Director, Patient Engagement
Associate Director, Patient Engagement

CSL • Thatcham

Hybrid
GBP 90,000 - 130,000
Senior Analyst, Planning and Reporting
Senior Analyst, Planning and Reporting

CSL • Liverpool

On-site
GBP 55,000 - 85,000
Associate Director, Patient Engagement
Associate Director, Patient Engagement

Csl • Maidenhead

Hybrid
GBP 90,000 - 130,000
Senior Director, Search & Evaluation Late TA Lead, Immunology
Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL • Maidenhead

Hybrid
GBP 180,000 - 240,000
Associate Director, Medical Evaluator - Global Case Management
Associate Director, Medical Evaluator - Global Case Management

Csl • Maidenhead

On-site
GBP 120,000 - 150,000
Senior Manager, Financial Accounting
Senior Manager, Financial Accounting

0603 Seqirus UK Limited • Liverpool

Hybrid
GBP 70,000 - 95,000
Hybrid working
Competitive benefits
Regional Regulatory Lead - APAC, LATAM, MEA, CIS, Adriatics and Partner Business
Regional Regulatory Lead - APAC, LATAM, MEA, CIS, Adriatics and Partner Business

0603 Seqirus UK Limited • Thatcham

Hybrid
GBP 90,000 - 120,000
Director (M/F/X), Hae / Andembry Brand Lead
Director (M/F/X), Hae / Andembry Brand Lead

Csl • South Harting

On-site
GBP 120,000 - 160,000
Enterprise Manager, Emea Trade Compliance
Enterprise Manager, Emea Trade Compliance

Csl • Maidenhead

On-site
GBP 120,000 - 180,000